Skip to main content
Caplight Logo









Biophelion GmbH

Biophelion GmbH

Private
JenaEnergy & Sustainabilityhttps://www.biophelion.com/

Last Round

Grant

Jul 1, 2025

Total Funding Raised

$6.93M

Company Overview

Biophelion GmbH is a biotechnology company that develops fermentation-based processes to convert industrial waste into specialty ingredients such as aroma molecules and biosurfactants.

Sector

Energy & Sustainability

Verticals

Biotechnology, Circular Economy, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologyfermentationprecision fermentationbiosurfactantcircular bioeconomyspecialty ingredientsindustrial wastebiomanufacturingsustainable chemistryflavor ingredientsgreen chemistrybiotech platformsynthetic biologywaste-to-valuebioprocessing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biophelion GmbH Comparables

Compare Biophelion GmbH with similar companies based on industry and business-model similarity.

Biophelion GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ruby Bio
83%
AmphiStar
81%
BIOWEG
78%

Biophelion GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2025

Key People

Founding team and executive leadership

Till Tiso

CTO and Co-founder

Founding Team

Lars Regestein

CEO & Co-Founder

Founding Team

Biophelion GmbH Investors

Notable investors and investment history

Biophelion GmbH investors
InvestorRounds
SPRINDGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Grew from 3 to 7 employees this quarter.

  • Feb 1, 2026

    Grew 100% QoQ from 3 to 6 employees.

Biophelion GmbH Filings

Explore SEC and related filing metadata, where available.

Biophelion GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biophelion GmbH's valuation, stock price, and market status.

Is Biophelion GmbH a public or private company?

Biophelion GmbH is a private company.

What is the current stock price of Biophelion GmbH?

Biophelion GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is Biophelion GmbH worth (valuation)?

Valuation information for Biophelion GmbH is not publicly available.

Can I buy Biophelion GmbH stock?

Biophelion GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biophelion GmbH's last funding round?

Biophelion GmbH's most recent funding round was Grant on July 1, 2025.

Who are the main investors in Biophelion GmbH?

Key investors in Biophelion GmbH include SPRIND.

Will Biophelion GmbH IPO soon?

No public IPO plans have been announced for Biophelion GmbH.

How can I track Biophelion GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biophelion GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJena
Employee Range8
Year Founded2025
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?